See LEGEND for key to shading and symbols.
Subject Area - BABS Term - Term 3 2022
| BABS1111 | BABS1201 | BABS2204 | BABS2264 | BABS3021 | BABS3061 |
| BABS3199 | BABS3200 | BABS3281 | BABS3299 | BABS3301 | BABS4516 |
| BABS5019 | BABS5029 | BABS5039 | BABS7180 | BABS8050 | BABS8100 |
Data is correct as at Thu May 19 18:01:03 AEST 2022
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| BABS1111 | Big Fat Myths | ||||||
| CRS | CR01 | 2002 | Open | 43/330 | 13% | (Course Enrolment, UGRD) | |
| BABS1201 | Molecules, Cells and Genes | ||||||
| CRS | CR01 | 2003 | Open | 132/320 | 41% | (Course Enrolment, UGRD) | |
| BABS2204 | Genetics | ||||||
| CRS | CR01 | 2004 | Open | 130/256 | 51% | (Course Enrolment, UGRD) | |
| BABS2264 | Genetics (Advanced Level) | ||||||
| CRS | CR01 | 2005 | Open | 26/60 | 43% | (Course Enrolment, UGRD) | |
| BABS3021 | Microbial Genetics | ||||||
| CRS | CR01 | 2006 | Open | 18/36 | 50% | (Course Enrolment, UGRD) | |
| BABS3061 | Medical Biotechnology | ||||||
| CRS | CR01 | 2007 | Open | 61/79 | 77% | (Course Enrolment, UGRD) | |
| BABS3199 | BABS Work Placement 1 | ||||||
| CRS | CR01 | 3404 | Open* | 0/90 | 0% | (Course Enrolment, UGRD) | |
| WKS | WSKA | 3470 | Enr | Open* | 0/30 | 0% | Wed 18-19:30 (w2,5,10) |
| WKS | WSKB | 3471 | Enr | Open* | 0/30 | 0% | Wed 18-19:30 (w2,5,10) |
| WKS | WSKC | 3472 | Enr | Open* | 0/30 | 0% | Wed 18-19:30 (w2,5) |
| BABS3200 | Synthetic Biology | ||||||
| CRS | CR01 | 2008 | Open | 62/64 | 97% | (Course Enrolment, UGRD) | |
| BABS3281 | Molecular Frontiers | ||||||
| CRS | CR01 | 2009 | Open | 44/60 | 73% | (Course Enrolment, UGRD) | |
| BABS3299 | BABS Work Placement 2 | ||||||
| CRS | CR01 | 3407 | Open* | 0/60 | 0% | (Course Enrolment, UGRD) | |
| WKS | WSKA | 3473 | Enr | Open* | 0/30 | 0% | |
| WKS | WSKB | 3474 | Enr | Open* | 0/30 | 0% | Wed 18-19:30 (w10) |
| BABS3301 | Biochem Lab Project | ||||||
| CRS | CR01 | 2010 | Open* | 0/15 | 0% | (Course Enrolment, UGRD) | |
| BABS4516 | Biotech and Biomolecular Hons | ||||||
| CRS | CR01 | 2011 | Open | 40/80 | 50% | (Course Enrolment, UGRD) | |
| BABS5019 | Research Project (6 UOC) | ||||||
| CRS | CR01 | 2442 | Open | 0/5 | 0% | (Course Enrolment, PGRD) | |
| BABS5029 | Research Project (12 UOC) | ||||||
| CRS | CR01 | 2443 | Open | 0/5 | 0% | (Course Enrolment, PGRD) | |
| BABS5039 | Research Project (18 UOC) | ||||||
| CRS | CR01 | 2444 | Open | 0/5 | 0% | (Course Enrolment, PGRD) | |
| BABS7180 | Research Techniques | ||||||
| CRS | CR01 | 2445 | Open | 0/3 | 0% | (Course Enrolment, PGRD) | |
| BABS8050 | Research Thesis Part-Time | ||||||
| CRS | CR01 | 2265 | Open | 0/9 | 0% | (Course Enrolment, RSCH) | |
| THE | THE1 | 3273 | Enr | Open | 1/10 | 10% | |
| BABS8100 | Research Thesis Full-Time | ||||||
| CRS | CR01 | 2266 | Open | 1/8 | 13% | (Course Enrolment, RSCH) | |
| THE | THE1 | 3272 | Enr | Open | 2/10 | 20% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |